Repository logo
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
Repository logo
    Communities & Collections
    Research Outputs
    Fundings & Projects
    People
    Organizations
    Statistics
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
  1. Home
  2. TMU Publications / 北醫出版品
  3. .博碩士學位論文
  4. .98學年度
  5. 結合檢驗資訊之智慧型用藥安全警示系統
 
  • Details
Options

結合檢驗資訊之智慧型用藥安全警示系統

Other Title
An intelligent drug safety system with integration of laboratory information
Type
thesis
Date Issued
2010-06-29
Author(s)
蘇群堯
Advisor
邱泓文
Subjects
系所名稱:醫學資訊研究所
Description
學位別:碩士
語文別:中文
指導教授:邱泓文
共同指導教授:
口試委員:朱唯勤;許明暉
中文關鍵字:用藥安全;智慧型用藥安全警示系統;監控檢驗;用藥疏失
Abstract
在醫療錯誤的行為中約有49%發生於處方開立過程中,在醫師端開立處方時有醫囑電腦化輸入系統(CPOE)可以來有效降低醫師輸入錯誤的機會,而在藥師端卻沒有一套配套系統來輔助藥師評估處方。

在評估處方的過程中時常需要檢驗資料來做輔助判斷的依據,此時藥師就必須藉由院內資訊系統來查詢該名病患之檢驗數據。但在上述步驟當中往往浪費了許多時間且皆無任何警示事件可以提供第二道防線來保護病患之用藥安全,所以本研究將在藥師評估處方時結合檢驗資料提供給藥師一份用藥高風險清單以輔助判斷。

本研究設計一套智慧型用藥安全警示系統能夠透過Web介面即時可以得到各項檢驗值與藥物注意事項,另外資料回傳伺服器端時透過Knowledge Base所建立的規則判斷,可以立即回傳至使用者端(藥師)目前用藥處於高風險的清單以及檢驗、藥物相關資訊,提供藥師對於該名病患所需監控檢驗是否有超出標準值或是已經達到危險的地步,透過Web界面即可得知該名病患所服用藥物及檢驗資訊與是否在高風險用藥清單內。

本論文所建構完成之結合檢驗資訊之智慧型用藥安全警示系統經白箱測試後,在測試總數:90筆之下分別由warfarin、carbamazepine、metformin藥物各為30筆的模擬資料,並且在各藥物之間亦加入檢驗值超標、缺乏檢驗值以及檢驗值正常之數據,經測試後在三項高風險藥物當中本系統之準確性皆可達到100%。另外在萬芳醫院99年1月至3月的連續資料當中,Warfarin藥物透過智慧型用藥安全警示系統判定為缺乏檢驗數據之藥物處方達95.7%(564/589)及Carbamazepine藥物被智慧型用藥安全警示系統判定為用藥高風險清單達18.6%(13/70)。

所以本研究可讓使用者更加了解到高風險藥物使用情形及達到提醒藥師本身所遺漏到須注意的高風險藥物處方,讓藥師更有效率在執業時不需多花時間與精力再去做查詢的動作且更容易來評估處方,期待能有效降低用藥疏失的產生。
URI
https://203.71.86.71/handle/123456789/13317

Copyright Notice

● The digital content on this platform is part of the Taipei Medical University Institutional Repository, featuring various academic works and outputs from the institution. It offers free access to academic research and public education for non-commercial use.

● Please use the content appropriately and within legal boundaries to respect copyright owners' rights. For commercial use, please obtain prior authorization from the copyright owner. Users must not use TMUIR for any illegal purposes.

● By utilising the platform, users are deemed to have fully accepted and understood all the regulations set out in this statement, relevant laws of the Republic of China, all international internet regulations, and usage conventions.

● TMUIR is committed to protecting the interests of copyright owners. If you believe that any material on this website infringes copyright, please contact our staff at libirtmu@gmail.com, and we will remove the work from the repository.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Cookie settings
  • Privacy policy
  • End User Agreement
  • Send Feedback